Publication Name	World Journal of Hepatology
Manuscript ID	92360
Country	India

Received	2024-01-23 12:13
Peer-Review Started	2024-01-23 12:13
To Make the First Decision
Return for Revision	2024-02-27 04:25
Revised	2024-03-05 14:56
Second Decision	2024-04-07 01:08
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-04-07 02:49
Articles in Press	2024-04-07 02:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-04-10 05:58
Publish the Manuscript Online	2024-04-24 08:35

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Metabolic dysfunction-associated steatotic liver disease: A silent pandemic
Manuscript Source	Invited Manuscript
All Author List	Arghya Samanta and Moinak Sen Sarma
Funding Agency and Grant Number
Corresponding Author	Moinak Sen Sarma, MBBS, MD, Adjunct Associate Professor, Doctor, Department of Pediatric Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Road, Lucknow 226014, India. moinaksen@yahoo.com
Key Words	Metabolic dysfunction; Fatty liver; Obesity; Insulin resistance
Core Tip	Non-alcoholic fatty liver disease is often considered the hepatic manifestation of metabolic syndrome. The new nomenclature of “metabolic dysfunction associated steatotic liver disease” emphasizes the role of disordered metabolism in the pathogenesis. Weight reduction by lifestyle changes is the mainstay of treatment.
Publish Date	2024-04-24 08:35
Citation	Samanta A, Sen Sarma M. Metabolic dysfunction-associated steatotic liver disease: A silent pandemic. World J Hepatol 2024; 16(4): 511-516
URL	https://www.wjgnet.com/1948-5182/full/v16/i4/511.htm
DOI	https://dx.doi.org/10.4254/wjh.v16.i4.511

Full Article (PDF)	WJH-16-511-with-cover.pdf
Manuscript File	92360_Auto_Edited-YJP.docx
Answering Reviewers	92360-Answering reviewers.pdf
Audio Core Tip	92360-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	92360-Conflict-of-interest statement.pdf
Copyright License Agreement	92360-Copyright license agreement.pdf
Peer-review Report	92360-Peer-review(s).pdf
Scientific Misconduct Check	92360-CrossCheck.png
Scientific Misconduct Check	92360-Bing-Gong ZM-2.png
Scientific Editor Work List	92360-Scientific editor work list.pdf